Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: China Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20172
20182
20198
20205
20216
20229
202312
202410
202513
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting32
Unknown status25
Completed11
Not yet recruiting7
Active, not recruiting4
Terminated4
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital6
RemeGen Co., Ltd.5
Sichuan Baili Pharmaceutical Co., Ltd.4
Abbisko Therapeutics Co, Ltd3
Mabwell (Shanghai) Bioscience Co., Ltd.3
Tianjin Medical University Second Hospital3
Affiliated Hospital of Jiangnan University2
BeiGene2
Fudan University2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell87
Urinary Bladder Neoplasms21
Carcinoma, Non-Small-Cell Lung8
Carcinoma, Renal Cell7
Endometrial Neoplasms6
Uterine Cervical Neoplasms6
Breast Neoplasms5
Melanoma5
Squamous Cell Carcinoma of Head and Neck5
Colorectal Neoplasms4

Trials

Showing 51 to 75 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.